ING Barings Ups MiniMed Rating to Strong Buy

Rating on medical device maker raised due to valuation

ING Barings upgraded its investment rating on medical device maker MiniMed > (MNMD ) to strong buy from buy due to valuation, adding that the stock dropped after a pre-announcement that was already affecting the stock.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.